Zai Lab Reports Q3 2026 Financial Results
Zai Lab reported $108.2 million in Q3 2026 revenues. The company announced major catalysts in 2027 for its Zoci product in small cell lung cancer and ZL-1503 in immunology.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed